Schonfeld Strategic Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $666K | Buy |
57,487
+26,558
| +86% | +$308K | ﹤0.01% | 1370 |
|
|
2025
Q1 | $270K | Sell |
30,929
-120,764
| -80% | -$1.05M | ﹤0.01% | 1706 |
|
|
2024
Q4 | $2.18M | Buy |
151,693
+88,583
| +140% | +$1.27M | 0.01% | 747 |
|
|
2024
Q3 | $1.43M | Buy |
63,110
+37,890
| +150% | +$856K | 0.01% | 906 |
|
|
2024
Q2 | $491K | Sell |
25,220
-7,477
| -23% | -$145K | ﹤0.01% | 1370 |
|
|
2024
Q1 | $1.23M | Buy |
32,697
+11,047
| +51% | +$415K | 0.01% | 992 |
|
|
2023
Q4 | $1.21M | Buy |
+21,650
| New | +$1.21M | 0.01% | 898 |
|
|
2023
Q3 | – | Sell |
-8,800
| Closed | -$491K | – | 2104 |
|
|
2023
Q2 | $491K | Buy |
+8,800
| New | +$491K | ﹤0.01% | 1198 |
|
|
2022
Q4 | – | Sell |
-34,200
| Closed | -$974K | – | 2908 |
|
|
2022
Q3 | $974K | Buy |
+34,200
| New | +$974K | 0.01% | 1267 |
|
|
2021
Q2 | – | Sell |
-12,281
| Closed | -$2.22M | – | 2269 |
|
|
2021
Q1 | $2.22M | Sell |
12,281
-219
| -2% | -$39.6K | 0.03% | 601 |
|
|
2020
Q4 | $1.77M | Buy |
12,500
+2,630
| +27% | +$372K | 0.02% | 600 |
|
|
2020
Q3 | $1.23M | Buy |
9,870
+770
| +8% | +$96K | 0.02% | 616 |
|
|
2020
Q2 | $813K | Hold |
9,100
| – | – | 0.02% | 628 |
|
|
2020
Q1 | $567K | Buy |
+9,100
| New | +$567K | 0.04% | 540 |
|